Encompass Health Corporation (EHC)

From the record

Encompass Health Corporation's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Encompass Health Corporation's 10 filed years say what it did: revenue went from $3.6 billion in fiscal 2016 to $5.9 billion in fiscal 2025, up 5.6% a year; it rose in 8 of 9 years; the deepest fall was 23% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Encompass Health Corporation's diluted share count grew about 0.6% a year, and dividends and buybacks returned about 13% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 18 sales and 0 purchases of their own stock on the open market in the year to 2026-10-19 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Encompass Health Corporation earned about 23 cents of profit for every dollar of shareholders' money. Leverage: it owed about 66 cents per dollar of assets, and net share issuance: its share count was unchanged over the year (the filed statements).

From the record

Encompass Health Corporation's standing among 22 graded names in its industry family: revenue of $5.9 billion in fiscal 2025 ranks in the top 30% by size; a net margin of 9.5% ranks in the top 11%; revenue growth of 10.9% a year over the last 3 filed years ranks in the top 34% (its annual reports).

From the record

Encompass Health Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Tarr, Mark J (President & CEO, as filed), filing under that title since 2017-01-05, 9.9 years (top 18% of its family); the 16 officers and directors filing in the last fifteen months have been on the record a median of 9.8 years (top 19%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 16 people in charge now (top 50%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Encompass Health Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $72 million against debt of $2.4 billion leaves -33.5% of its assets as net cash, top 45% of its family; cash from operations less capital spending is 7.4% of revenue (top 48%) (its annual report).

From the record

Encompass Health Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 10.9% a year over the last three filed years against 5.6% over all 10, speeding up (top 16% of its family); the newest year grew 10.5% (top 43%); capital spending grew 8% a year (top 34%) (its annual reports). Encompass Health Corporation reported 2 product lines in fiscal 2025: Inpatient at $5.8 billion (97%), Other at $179 million (3%); 2 of 2 grew against the year before (its annual report).

From the record

Encompass Health Corporation's newest year against its own record: revenue of $5.9 billion in fiscal 2025 came in 0.6% below the $6.0 billion its prior three years' pace pointed to (bottom 48% of its family); net income of $566 million against a prior three-year average of $360 million (top 48%); a net margin of 9.5% against 7.3% before (top 34%) (its annual reports).